89BIO INC's ticker is ETNB and the CUSIP is 282559103. A total of 152 filers reported holding 89BIO INC in Q1 2023. The put-call ratio across all filers is 0.33 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $19,981,719 | -10.4% | 1,293,988 | +9.9% | 0.00% | -33.3% |
Q2 2023 | $22,303,947 | +190.6% | 1,176,989 | +133.6% | 0.00% | +200.0% |
Q1 2023 | $7,675,087 | +175250.4% | 503,945 | +46.6% | 0.00% | 0.0% |
Q4 2022 | $4,377 | -99.7% | 343,856 | +42.3% | 0.00% | – |
Q3 2022 | $1,399,000 | +377.5% | 241,708 | +165.5% | 0.00% | – |
Q2 2022 | $293,000 | -53.7% | 91,045 | -45.8% | 0.00% | – |
Q1 2022 | $633,000 | -70.6% | 167,942 | +1.8% | 0.00% | – |
Q4 2021 | $2,156,000 | -38.3% | 165,001 | -7.5% | 0.00% | – |
Q3 2021 | $3,493,000 | +18.8% | 178,325 | +13.4% | 0.00% | – |
Q2 2021 | $2,940,000 | -13.2% | 157,268 | +9.9% | 0.00% | -100.0% |
Q1 2021 | $3,387,000 | +11.8% | 143,064 | +15.1% | 0.00% | 0.0% |
Q4 2020 | $3,029,000 | +20.3% | 124,325 | +26.7% | 0.00% | – |
Q3 2020 | $2,517,000 | +78.0% | 98,091 | +38.2% | 0.00% | – |
Q2 2020 | $1,414,000 | -18.8% | 70,954 | +2.8% | 0.00% | – |
Q1 2020 | $1,742,000 | -40.9% | 69,002 | -38.4% | 0.00% | – |
Q4 2019 | $2,946,000 | – | 112,066 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RA Capital Management | 11,416,948 | $173,880,118 | 3.94% |
Orchard Capital Management, LLC | 551,879 | $8,405,117 | 2.81% |
Cormorant Asset Management, LP | 2,800,000 | $42,644 | 2.81% |
SILVERARC CAPITAL MANAGEMENT, LLC | 438,215 | $6,674,014 | 2.76% |
Boxer Capital, LLC | 2,100,000 | $31,983 | 1.57% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 2,210,536 | $33,666,463 | 1.42% |
Resolute Capital Asset Partners LLC | 125,000 | $1,904 | 1.39% |
Velan Capital Investment Management LP | 98,500 | $1,500,155 | 1.28% |
SILVERARC CAPITAL MANAGEMENT, LLC | 200,000 | $3,046,000 | 1.26% |
Deep Track Capital, LP | 1,800,000 | $27,414,000 | 1.13% |